The Body and Brain in IBS Study: Evaluating the effects of fructans on gastrointestinal symptoms in adults with mild to moderate IBS

Deakin University0 个研究点目标入组 20 人开始时间: 2024年8月28日最近更新: 2024年9月2日

适应症

试验速览

暂无简介。

•Australian residents willing to drive to Geelong for one study visit
•Aged 18-65 years
•IBS diagnosed by GP or gastroenterologist and meeting the Rome IV criteria (screened at
•Mild or moderate IBS symptoms (IBS-SSS score 75-300 pts)
•Familiar with fermentable oligosaccharides, disaccharides, monosaccharides and polyols (FODMAPs) and fructans
•Access to internet on phone, tablet or computer
•Able to read and understand materials written in English

•Patient-reported diagnosis of other gastrointestinal diseases (e.g. inflammatory bowel disease, acute diverticulitis coeliac disease)
•Patient-reported diagnosis of unstable mental illness (e.g. unstable schizophrenia, other psychotic disorders)
•Patient-reported diagnosis of current major medical conditions (e.g., cancer, dementia, type 1 and type 2 diabetes, cardiovascular disease, heart failure, chronic obstructive pulmonary disease).
•Patient-reported alcohol/substance abuse
•Eating disorder such as anorexia nervosa and bulimia nervosa (i.e. patient-reported or score equal to or greater than 3 on the ‘Sick, Control, One, Fat, Food’ (SCOFF) questionnaire)
•Pregnant, planning pregnancy or lactating
•Previous extensive GI surgery or stenotic disease e.g., major bowel resection, cholecystectomy (not appendicectomy or haemorrhoidectomy)
•Commenced prebiotics, probiotics or antibiotics in the past 4 weeks
•Current participation in another clinical trial
•Commencement or change in therapy for irritable bowel syndrome in the past month.

发起方